• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-08-03

  This study provides a comprehensive molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China. The findings highlight the predominance of plasmid-mediated blaNDM-1, extensive multidrug resistance, and the mobility of resistance genes, informing strategies for surveillance and experimental resistance modeling.

• Oral Faropenem Sodium: Resistance Risks and Treatment Effect

  2026-08-03

  This article reviews the implications of oral faropenem sodium use for antimicrobial resistance (AMR) and clinical effectiveness, focusing on its increasing adoption, mechanism, and regulatory landscape. The reference study highlights concerns regarding overuse, cross-resistance with carbapenems, and the need for stewardship, especially in high-consumption regions.

• Isorhamnetin: Enhancing Oocyte Maturation via PI3K/Akt Activ

  2026-08-02

  Isorhamnetin, a distinctive flavonoid, unlocks new precision in oxidative stress and apoptosis research by modulating PI3K/Akt pathways. This guide details advanced workflows, troubleshooting strategies, and practical insights for deploying Isorhamnetin in reproductive cell biology assays.

• Lenalidomide (CC-5013): Next-Generation Immunomodulation in

  2026-08-01

  Explore how Lenalidomide (CC-5013) transforms multiple myeloma research through multi-modal immune system activation and epigenetic synergy. Discover unique insights into assay design and mechanistic innovation supported by recent breakthroughs.

• Targeting Plasmodium Aminopeptidases: Phebestin’s Antiplasmo

  2026-07-31

  The referenced study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent with nanomolar efficacy against both chloroquine-sensitive and -resistant strains of Plasmodium falciparum. The research demonstrates phebestin’s ability to inhibit parasite growth across all intraerythrocytic stages and reduce parasitemia in vivo, providing a mechanistically distinct lead for antimalarial drug development.

• Human NPT1 as a Renal Apical Transporter for Faropenem Sodiu

  2026-07-31

  This study provides the first molecular evidence that human NPT1, an inorganic phosphate transporter in the renal apical membrane, actively mediates the transport of organic anions such as p-aminohippuric acid (PAH) and antibiotics like faropenem. These findings clarify the mechanistic basis of renal secretion for diverse organic anions, with implications for dosing, drug interaction research, and antibiotic resistance studies.

• Artesunate (SKU B3662): Data-Driven Solutions for Oncology L

  2026-07-30

  This article addresses persistent challenges in cell viability and cytotoxicity assays by demonstrating how Artesunate (SKU B3662), a high-purity artemisinin derivative, delivers reproducible, sensitive, and mechanistically clear results in cancer research. Drawing on validated protocols and evidence from the literature, we provide scenario-driven guidance for bench scientists aiming to maximize experimental reliability and interpretability with Artesunate.

• Supramolecular Chlorogenic Acid–Metal Complexes Enhance Anti

  2026-07-30

  The reference study demonstrates that supramolecular assemblies of chlorogenic acids with iron and copper ions significantly amplify anti-inflammatory activity by targeting the NF-κB pathway in vitro. This innovative approach highlights the potential of metal-mediated self-assembly to boost the bioactivity of natural products, offering new strategies for inflammation modulation.

• Optimized hiPSC-to-Platelet Differentiation: A Small Molecul

  2026-07-29

  This study presents an optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs). By refining embryoid body dosing, utilizing a serum-free medium with human platelet lysate, and strategically substituting cytokines with small molecules, the method increases yield, reduces cost, and shortens timelines—addressing key challenges in scalable platelet production.

• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-07-29

  This study details an optimized, cost-effective protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs). By increasing embryoid body cell input and strategically substituting cytokines with small molecules, the method accelerates differentiation, boosts yield, and reduces costs, addressing key barriers in scalable platelet manufacturing.

• Triiodothyronine (T3) in Metabolic Research: Protocols & Pit

  2026-07-28

  Triiodothyronine (T3) is a pivotal tool for modeling thyroid hormone signaling and metabolic regulation in vitro and in vivo. This guide distills actionable workflows, troubleshooting strategies, and translational insights, leveraging high-purity T3 (SKU C6407, APExBIO) for robust, reproducible metabolic disorder research.

• Selective Spectrophotometric Analysis of Phenolic β-Lactam A

  2026-07-28

  The reference study introduces two optimized spectrophotometric methods for the selective quantification of phenolic β-lactam antibiotics in pure form and pharmaceutical combinations, including those with dicloxacillin. These protocols address analytical gaps left by standard chromatographic techniques, providing accessible, accurate solutions for quality control and formulation analysis.

• HyperFusion High-Fidelity DNA Polymerase in Neurogenomics PC

  2026-07-27

  HyperFusion™ high-fidelity DNA polymerase from APExBIO empowers researchers to tackle challenging PCR tasks—such as GC-rich template amplification and highly accurate cloning—by blending unmatched fidelity with robust inhibitor tolerance. Its engineered mechanism and proven performance in neurodegeneration research make it the go-to enzyme for precision molecular workflows demanding reliability and reproducibility.

• Cefazedone (Refosporen): Advanced PK/PD and Resistance Insig

  2026-07-27

  Explore the advanced pharmacokinetic and pharmacodynamic properties of Cefazedone (Refosporen), a first-generation cephalosporin, with a focus on resistance mechanisms and cutting-edge assay guidance. This article offers new perspectives on in vitro and clinical applications for researchers and clinicians.

• Cefazedone (Refosporen): Applied Workflows and Antibacterial

  2026-07-26

  Cefazedone (Refosporen) offers robust, β-lactamase-resistant efficacy for Gram-positive and Gram-negative infections, excelling in both in vitro and translational workflows. This article delivers optimized protocols, troubleshooting strategies, and practical insights for maximizing research reproducibility and clinical relevance with APExBIO's Cefazedone.

448 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page